Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Percheron Therapeutics ( (AU:PER) ) has shared an announcement.
Percheron Therapeutics, a company involved in the biotechnology sector, recently responded to an inquiry from the Australian Securities Exchange regarding a director’s trading activities. The company clarified its compliance with disclosure obligations, detailing the approval process for Dr. James Garner’s share transactions. The misunderstanding about trading periods was attributed to an outdated understanding of the company’s Securities Trading Policy, which had been updated in late 2024.
More about Percheron Therapeutics
Average Trading Volume: 10,000
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $6.8M
See more data about PER stock on TipRanks’ Stock Analysis page.